We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

With many of the Magnificent 7 stocks reporting earnings the week of October 28, investors’ attention was on technology ...

Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's ...

Shares of Merck & Co. Inc. MRK slipped 0.48% to $103.73 Tuesday, on what proved to be an all-around mixed trading session for ...

Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...

In a report released yesterday, Mohit Bansal from Wells Fargo assigned a Hold rating on Merck & Company (MRK – Research Report), ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), reducing the price ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $103.98 which represents a decrease of $-1.90 or -1.79% from the prior close of $105.88. The stock opened at $106.49 and touched ...

Despite a strong Q2, Merck's stock fell due to concerns over Gardasil and Winrevair. See more on MRK stock and its ...

2024 EPS Guidance: $7.72 to $7.77. Merck & Co Inc (NYSE:MRK) reported a 4% increase in revenues for the quarter, or 7% on a constant currency basis, driven by strong performance in key areas like ...

Merck & Co reported stronger-than-expected quarterly earnings thanks to rising Keytruda sales. However, Gardasil's weak ...